NYSEMKT: IBO
Impact Biomedical Inc Earnings Dates, Reports, Calls

Impact Biomedical earnings were -$24.7M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest IBO earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$27.1M, down 738.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IBO reported annual earnings of -$24.7M, with 469.8% growth.

IBO earnings history

Current Revenue
$0.0
Current Earnings
-$24.7M
Current Profit Margin
0%

IBO Return on Equity

Current Company
-118.7%
Current Industry
-2%
Current Market
34.1%
IBO's Return on Equity (-118.7%)... subscribe to Premium to read more.
High Return on Equity Performance

IBO undefined

Current Company
-63.6%
Current Industry
-0.4%
IBO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IBO announces earnings.

IBO undefined

Current Company
-224.75%
Current Industry
5.9%

IBO vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IBO-$22.49M-$24.71MN/A-$2.30
APM-$3.82M-$4.27MN/A-$0.78
GTBP-$13.16M-$13.16MN/A-$6.94
AZTR-$8.50M-$8.97MN/A-$2.37
CERO-$6.72M-$10.52MN/A-$18.15

Impact Biomedical Earnings Reports & History FAQ

What were Impact Biomedical's earnings last quarter?

Impact Biomedical (NYSEMKT: IBO) reported Q4 2024 earnings per share (EPS) of -$2.53, up 8,333.33% year over year. Total IBO earnings for the quarter were -$27.11 million. In the same quarter last year, Impact Biomedical's earnings per share (EPS) was -$0.03.

If you're new to stock investing, here's how to buy Impact Biomedical stock.

Is Impact Biomedical profitable or losing money?

As of the last Impact Biomedical earnings report, Impact Biomedical is currently losing money. Impact Biomedical's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$24.71 million, a 469.83% increase year over year.

What was IBO's earnings growth in the past year?

As of Impact Biomedical's earnings date in Q2 2025, Impact Biomedical's earnings has grown year over year. IBO earnings in the past year totalled -$24.71 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.